In scenarios such as TGF-β induced EMTand tumor-initiating cells, ITGB3 is upregulated, leading to increasedmigration, invasion, maintenance of stemness, and consequent resistanceto targeted therapies. The gene discussed is TGFB1; the disease is neoplasm.